Galderma Group AG

🇨🇭Switzerland
Ownership
-
Employees
-
Market Cap
$22.9B
Website
http://www.galderma.com/

Pan Facial Volume Restoration

First Posted Date
2012-03-06
Last Posted Date
2023-03-01
Lead Sponsor
Galderma R&D
Target Recruit Count
60
Registration Number
NCT01545557
Locations
🇧🇷

Galderma Investigational Center, Saö Paulo, Brazil

An Open, Uncontrolled Study of GK567 in the Deodorization of Malodorous Fungating Neoplastic Tumours

Phase 3
Completed
Conditions
Interventions
First Posted Date
2012-03-01
Last Posted Date
2014-02-06
Lead Sponsor
Galderma R&D
Target Recruit Count
21
Registration Number
NCT01541930
Locations
🇯🇵

Galderma investigational site, Tokyo, Japan

Subjects' Satisfaction on Pan Facial Aesthetic Enhancement After Treatment With Azzalure® and the Restylane® Range

First Posted Date
2012-02-08
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
60
Registration Number
NCT01529203
Locations
🇬🇧

Galderma investigational site, Street, United Kingdom

Split-face Tolerability Comparison Between Adapalene-Benzoyl Peroxide Gel Versus Tretinoin Gel

First Posted Date
2012-01-31
Last Posted Date
2022-08-01
Lead Sponsor
Galderma R&D
Target Recruit Count
73
Registration Number
NCT01522456
Locations
🇺🇸

Stephens and Associates, Dallas, Texas, United States

Phase 3 Papulopustular Rosacea Study

First Posted Date
2011-12-19
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
688
Registration Number
NCT01494467
Locations
🇺🇸

Burke Pharmaceutical Research, Hot Springs, Arkansas, United States

🇨🇦

Guildford Dermatology Specialists, Surrey, British Columbia, Canada

🇺🇸

Total Skin and Beauty, Birmingham, Alabama, United States

and more 45 locations

Phase 3 Papulopustular Rosacea Study

First Posted Date
2011-12-16
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
683
Registration Number
NCT01493687
Locations
🇺🇸

Dermatology Associates of Kingsport, PC, Kingsport, Tennessee, United States

🇨🇦

Eastern Canada Cutaneous Research Associates, Halifax, Nova Scotia, Canada

🇺🇸

UAB Dermatology Clinical Research, Birmingham, Alabama, United States

and more 47 locations

CD5024 1% [Ivermectin 1%] Cream Versus Metronidazole 0.75% Cream in Papulopustular Rosacea (PPR) Study

First Posted Date
2011-12-16
Last Posted Date
2015-10-28
Lead Sponsor
Galderma R&D
Target Recruit Count
962
Registration Number
NCT01493947
Locations
🇨🇿

Galderma Invetigational site, Olomouc, Czech Republic

🇬🇧

Galderma Investigational Site, Nuneaton, United Kingdom

Intra-individual Comparison of Efficacy and Safety of Metvix® Natural Daylight Photodynamic Therapy Versus Conventional Metvix® Photodynamic Therapy in Subject With Mild Actinic Keratoses

First Posted Date
2011-11-21
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
100
Registration Number
NCT01475071
Locations
🇦🇺

Galderma Investigational site, Carlton, Victoria, Australia

🇦🇺

Galderma Investigational Site, Kogarah, New South Wales, Australia

Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne

First Posted Date
2011-11-18
Last Posted Date
2021-02-18
Lead Sponsor
Galderma R&D
Target Recruit Count
266
Registration Number
NCT01474590
Locations
🇨🇦

Galderma investigational site, Woodbridge, Canada

A Study of Treatment Preference During Cheek Contouring Comparing Restylane® SubQ With and Without the Addition of Lidocaine Hydrochloride

First Posted Date
2011-09-12
Last Posted Date
2022-09-22
Lead Sponsor
Galderma R&D
Target Recruit Count
54
Registration Number
NCT01431755
Locations
🇸🇪

Plastikkirurggruppen, Stockholm, Sweden

🇸🇪

ZMedical, Stockholm, Sweden

🇸🇪

Akademikliniken, Stockholm, Sweden

© Copyright 2024. All Rights Reserved by MedPath